Business Description
Hologic Inc
NAICS : 334517
SIC : 3844
ISIN : US4364401012
Share Class Description:
HOLX: Ordinary SharesDescription
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.95 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.52 | |||||
| Debt-to-EBITDA | 2.1 | |||||
| Interest Coverage | 7.47 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.48 | |||||
| Beneish M-Score | -2.75 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.3 | |||||
| 3-Year EBITDA Growth Rate | -7.5 | |||||
| 3-Year EPS without NRI Growth Rate | -2.4 | |||||
| 3-Year FCF Growth Rate | 9 | |||||
| 3-Year Book Growth Rate | 25.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 6.23 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 3.54 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.59 | |||||
| 9-Day RSI | 52.78 | |||||
| 14-Day RSI | 51.82 | |||||
| 6-1 Month Momentum % | 7.51 | |||||
| 12-1 Month Momentum % | 24.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.99 | |||||
| Quick Ratio | 3.32 | |||||
| Cash Ratio | 2.43 | |||||
| Days Inventory | 130.4 | |||||
| Days Sales Outstanding | 59.66 | |||||
| Days Payable | 37.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 2.1 | |||||
| Shareholder Yield % | 6.36 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 54.43 | |||||
| Operating Margin % | 22.16 | |||||
| Net Margin % | 17.59 | |||||
| FCF Margin % | 25.44 | |||||
| ROE % | 14.23 | |||||
| ROA % | 7.87 | |||||
| ROIC % | 13.42 | |||||
| 3-Year ROIIC % | 1556.94 | |||||
| ROC (Joel Greenblatt) % | 77.67 | |||||
| ROCE % | 11.48 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 27.51 | |||||
| Forward PE Ratio | 18.67 | |||||
| PE Ratio without NRI | 19.71 | |||||
| Shiller PE Ratio | 28.18 | |||||
| Price-to-Owner-Earnings | 23.06 | |||||
| PEG Ratio | 0.37 | |||||
| PS Ratio | 4.87 | |||||
| PB Ratio | 3.79 | |||||
| Price-to-Tangible-Book | 19.3 | |||||
| Price-to-Free-Cash-Flow | 19.05 | |||||
| Price-to-Operating-Cash-Flow | 16.46 | |||||
| EV-to-EBIT | 20.9 | |||||
| EV-to-Forward-EBIT | 14.93 | |||||
| EV-to-EBITDA | 15.58 | |||||
| EV-to-Forward-EBITDA | 14.15 | |||||
| EV-to-Revenue | 4.76 | |||||
| EV-to-Forward-Revenue | 4.55 | |||||
| EV-to-FCF | 18.7 | |||||
| Price-to-Projected-FCF | 1.18 | |||||
| Price-to-Median-PS-Value | 1.24 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.02 | |||||
| Price-to-Graham-Number | 4.11 | |||||
| Price-to-Net-Current-Asset-Value | 323.48 | |||||
| Earnings Yield (Greenblatt) % | 4.78 | |||||
| FCF Yield % | 5.4 | |||||
| Forward Rate of Return (Yacktman) % | 25.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HOLX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hologic Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 3,987.6 | ||
| EPS (TTM) ($) | 2.94 | ||
| Beta | 0.71 | ||
| Volatility % | 15.52 | ||
| 14-Day RSI | 51.82 | ||
| 14-Day ATR ($) | 1.240508 | ||
| 20-Day SMA ($) | 80.748 | ||
| 12-1 Month Momentum % | 24.73 | ||
| 52-Week Range ($) | 65.55 - 84.67 | ||
| Shares Outstanding (Mil) | 232.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hologic Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hologic Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hologic Inc Frequently Asked Questions
What is Hologic Inc(HOLX)'s stock price today?
The current price of HOLX is $80.87. The 52 week high of HOLX is $84.67 and 52 week low is $65.55.
When is next earnings date of Hologic Inc(HOLX)?
The next earnings date of Hologic Inc(HOLX) is 2024-11-04.
Does Hologic Inc(HOLX) pay dividends? If so, how much?
Hologic Inc(HOLX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers